Andrew Rudd holds a PhD from UCSD and is the founder and CEO of Palm Therapeutics.

We shared some beer from Alesmith and talked about his company Palm and their work with Lipids. We also dug into the process of applying for grants and how that has been a valuable alternative to venture capital and what the next milestones are as they continue to grow.